Skip to content
OpenCapital
Get started

Stereotaxis STXS Enterprise value

Enterprise value at other companies

Abbott logo
AbbottABT
$205.65B-13.1%
Boston Scientific logo
Boston ScientificBSX
$141.04B-1.0%
Medtronic logo
MedtronicMDT
$131.22B-3.2%
Stryker logo
StrykerSYK
$137.35B-12.4%
ITG
Integer HoldingsITGR
$4.4B-19.6%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$4.43B-33.3%

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K—
Free cash flow-$3.5M—

Valuation

See full
Market cap$168.11M-11.6%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Calculated from Stereotaxis’s reported figures.

$178.9Mmarket cap+$5.3Mtotal debt−$14.6Mcash and equivalents=$169.6M

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's enterprise value?
Stereotaxis (STXS) reported enterprise value of $169.6M in Q1 2026.
How has Stereotaxis's enterprise value changed year-over-year?
Stereotaxis's enterprise value increased by 15.8% year-over-year, from $146.5M to $169.6M.
What is the long-term trend for Stereotaxis's enterprise value?
Over 5 years (2020 to 2025), Stereotaxis's enterprise value has grown at a -9.5% compound annual growth rate (CAGR), from $340.12M to $206.66M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.